| Cat.No. | Name | Information |
|---|---|---|
| M10249 | Teduglutide | Teduglutide is a glucagon-like peptide-2 (GLP-2) analogue used for the treatment of short-bowel syndrome. |
| M40590 | Pegsebrenatide | Pegsebrenatide is a compound that acts on GLP-1R. |
| M40589 | Froniglutide | Froniglutide is a GLP-1R-acting compound that increases muscle mass and strength by targeting GLP-1 receptors that are overexpressed in muscle, thereby acting directly on muscle cells. It can be used in studies related to dermatomyositis / polymyositis (DM / PM). |
| M40585 | TTP273 | TTP273 is a GLP-1R agonist that can be used in studies related to type 2 diabetes. |
| M40584 | TTP054 | TTP054 is a GLP-1R agonist that can be used in studies related to type 2 diabetes. |
| M40583 | RG7697 | RG7697 is a compound that acts on GLP-1R and GIPR. It can be used in studies related to diabetes. |
| M40582 | NN9389 | NN9389 is a compound that acts on GLP-1R and GIP. |
| M40580 | MEDI-4166 | MEDI-4166 is a novel GLP-1 analog of an anti-preprotein convertase chymotrypsin 9 (PCSK9) monoclonal antibody fused to GLP-1, as well as a GLP-1R agonist, which can be used in cardiovascular disease-related studies. |
| M40579 | MAR701 | MAR701 is a synthetic peptide that acts on GLP-1R as well as GIPR and can be used in studies related to type 2 diabetes. |
| M40578 | LY2428757 | LY2428757 is a GLP-1R agonist that can be used in studies related to type 2 diabetes. |
| M40577 | GX-G6 | GX-G6 is a GLP-1R agonist that can be used in studies related to type 2 diabetes. |
| M40576 | CT-868 | CT-868 is a GIPR and GLP-1R modulator for studies related to non-alcoholic steatohepatitis (NASH) and obesity. |
| M40574 | AC2592 | AC2592 is a synthetic peptide that acts on the GLP-1 receptor and can be used in studies related to cardiovascular disease and diabetes. |
| M40532 | AMG-133 | AMG-133 is an antibody-peptide coupler that activates the GLP-1R-mediated intracellular signaling pathway by coupling a GLP-1 polypeptide to the heavy chain of a GIPR antibody, thereby being able to inhibit GIPR while activating the GLP-1R-mediated intracellular signaling pathway. |
| M40524 | SCO-094 | SCO-094 is a GLP-1/GIP dual-target agonist with strong target binding activity and cell biological activity. It can be used in studies related to type 2 diabetes, obesity and non-alcoholic steatohepatitis (NASH). |
| M40523 | VK2735 | VK2735 is a novel GLP-1/GIPR dual agonist for studies related to metabolic diseases. |
| M38959 | Cochinchinenin C | Cochinchinenin C is a nonpolypeptide agonist of glucagon-like peptide-1 (GLP-1) receptor. Cochinchinenin C can be used for the research of diabetes. |
| M31373 | AZD0186 | AZD0186 is a GLP-1 receptor agonist that may be used in studies related to type 2 diabetes. |
| M31335 | Supaglutide | Supaglutide is a novel GLP-1 analog that is also a GLP-1R agonist. |
| M31334 | Albenatide | Albenatide is a synthetic peptide that is also a GLP-1 receptor agonist and can be used in studies related to type 2 diabetes. |
| M31217 | Utreglutide | Utreglutide is a potent glucagon-like peptide 1 (GLP-1) receptor agonit. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
